Screener
Travere Therapeutics, Inc. TVTX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
| Assets | March 31, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 34,347 | 28,760 |
| Total current assets | 392,681 | 437,565 |
| Long-term inventory | 30,698 | 30,280 |
| Property and equipment, net | 3,627 | 4,022 |
| Operating lease right of use assets | 9,668 | 10,576 |
| Intangible assets, net | 110,038 | 113,868 |
| Other assets | 8,476 | 8,880 |
| Total assets | $555,188 | $605,191 |
Item 1. Financial Statements
FAQ
- What is Travere Therapeutics, Inc.'s PP&E (net)?
- Travere Therapeutics, Inc. (TVTX) reported PP&E (net) of $3.63M in Q1 2026.
- How has Travere Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Travere Therapeutics, Inc.'s PP&E (net) decreased by 25.3% year-over-year, from $4.85M to $3.63M.
- What is the long-term trend for Travere Therapeutics, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s PP&E (net) has grown at a -15.6% compound annual growth rate (CAGR), from $9.42M to $4.02M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Travere Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude